Typically, ER+ breast cancer cell lines (or single cell PDX suspensions) could be implanted in the mammary fat pad, subcutaneously or via tail vein injection (Zhang et al. 1999, Holen et al. 2016, Özdemir et al. 2018, Jin et al. 2020). Here, ESR1 is linked to breast cancer.